Boston Scientific (BSX) Long-Term Debt Repayments (2009 - 2020)

Boston Scientific's Long-Term Debt Repayments history runs 11 years deep, the most recent figure standing at $1.4 billion for Q2 2020.

• In Q2 2020, Long-Term Debt Repayments changed N/A year-over-year to $1.4 billion; the TTM figure through Mar 2021 stood at $1.4 billion (up 200.63% YoY), while the FY2020 annual figure was $1.9 billion, changed N/A from the prior year.
• Long-Term Debt Repayments came in at $1.4 billion for Q2 2020 at Boston Scientific, up from $479.0 million in the prior quarter.
• In the past five years, Long-Term Debt Repayments ranged from a high of $1.6 billion in Q3 2017 to a low of -$1.2 billion in Q4 2017.
• A 4-year average of $405.8 million and a median of $335.0 million in 2016 frame the typical range for Long-Term Debt Repayments.
• Across the five-year window, Long-Term Debt Repayments slumped 480.0% in 2017 and soared 140.8% in 2018, its largest moves.
• Boston Scientific's Long-Term Debt Repayments stood at $320.0 million in 2016, then plunged by 480.0% to -$1.2 billion in 2017, then jumped by 97.29% to -$33.0 million in 2018, then soared by 4463.64% to $1.4 billion in 2020.
• According to Business Quant data, Long-Term Debt Repayments over the past three periods registered $1.4 billion, $479.0 million, and -$33.0 million for Q2 2020, Q1 2020, and Q2 2018 respectively.

Peer Comparison